Published on
Last updated on
China NMPA Medical Device Registration Timeline Calculator

Planning to launch a medical device in China? Use this interactive NMPA medical device registration timeline calculator to estimate your approval schedule and plan your market entry.
How Long Will NMPA Registration Take for Your Medical Device?
Answer a few quick questions about your device classification, clinical data and documentation readiness, and target start date. You will receive a preliminary month-by-month breakdown of key milestones, and an estimated approval window for registering your medical device with China's NMPA.
Once you have your results, share them with our regulatory specialists to map out a tailored strategy for China medical device market access.
End-to-End China NMPA Medical Device Registration Support
While this tool provides a reliable starting point, securing NMPA medical device approval requires navigating strict regulatory requirements — including local NMPA type testing, clinical evaluation or trials, and comprehensive Chinese-language technical dossiers.
Backed by over 20 years of local experience, Cisema manages the entire China medical device registration and filing lifecycle from start to finish:
- Classification & Pathway Assessment: Confirm whether your product falls under Class I, II, or III, identify the right NMPA registration pathway, and evaluate eligibility for clinical trial exemptions or expedited pathways.
- Technical & QMS Compliance Review: Align your Product Technical Requirements (PTR) and Quality Management System (QMS) with mandatory Chinese standards and China Medical Device GMP.
- Type Testing, CER & Dossier Preparation: Coordinate local testing at NMPA-accredited laboratories, close documentation gaps, and compile your Clinical Evaluation Report (CER) and submission dossier.
- China CRO & Clinical Trial Management: Design and execute China GCP-compliant clinical trials — including protocol development, ethics committee approvals, site selection, clinical monitoring, and statistical reporting — when local clinical data is required.
- NMPA Medical Device Registration & Filing Submission: Manage dossier submissions, respond to supplementary notices, and coordinate technical review communications with authorities.
- Legal Agent Representation: Act as your authorized domestic responsible agent in China to handle regulatory liaison, adverse event reporting, and post-market compliance obligations
Whether you are introducing an innovative Class III product or filing a Class I device, our team will build a clear, compliant regulatory roadmap tailored to your launch schedule.
To discuss your medical device registration in China and accelerate your market entry, contact Cisema today.
Further Information
Explore Cisema’s China medical device regulatory services:
- China NMPA Medical Device Registration & Filing
- China Medical Device Legal Agent Services
- China Medical Device CRO Services
See Cisema's Timeline Generator for Medical Device & IVD Clinical Trials in China.
Read more about medical devices in China:
- China Medical Device GMP vs. ISO 13485: Key Differences Explained
- How China Medical Device Risk Classification Determines the NMPA Registration Pathway
- A Regulatory Glossary for Medical Devices in China
- FAQ: China Medical Device & IVD Registration
- How Is SaMD & AI Medical Software Regulated in China? NMPA Requirements Guide
- How China IVD Risk Classification Determines Your NMPA Registration Pathway
Learn about medical device clinical trials in China:
Connect with Cisema
With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.
Stay Informed with Monthly News and Analysis
Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.





